protein sciences corporation biotech company based meriden connecticut company develops produces vaccines biopharmaceuticals use influenza diseases company acquired sanofi protein sciences developed novel method vaccine production using genetically modified baculovirus allowed reproduce insect method reduces lead time vaccine production six eight weeks considerably shorter conventional eggbased company applied biologic license application us food drug administration fda flublok seasonal influenza jan protein sciences announced us food drug administration approved flublok influenza vaccine use people years old since flubloks age indication expanded adults older october flublok currently httpsenwikipediaorgwikiflublok